Ribociclib (ribociclib) side effects to be aware of in the treatment of breast cancer

Ribociclib (Ribociclib), known by the trade name Kisqali, is an important treatment for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced or metastatic breast cancer. It exhibits significant therapeutic effects on breast cancer by inhibiting the activity of cyclin-dependent kinase 4/6 (CDK4/6). However, like other medications, ribociclib may come with a range of side effects. Awareness and prevention of these side effects are crucial to ensuring the safety and effectiveness of patient treatment.

1. Common side effects that need attention

1.Neutropenia: This is the most common side effect after taking ribociclib. Neutrophils are key to the body's fight against infection, and reduced numbers increase the risk of infection. Therefore, it is recommended that patients undergo regular blood tests during treatment. Once a significant decrease in the number of neutrophils is found, they should consult a doctor immediately. The drug dosage may need to be adjusted or other measures may be taken.

2.Increased liver enzyme levels:Ribociclib may cause an increase in liver enzymes, reflecting possible effects on liver function. Therefore, liver function monitoring before and after treatment is essential to ensure liver health.

3.Gastrointestinal problems: such as nausea, vomiting, diarrhea, etc. These discomforts may affect the patient's quality of life. It is recommended to adjust your diet, avoid irritating foods, and seek medical advice from your doctor if necessary.

4.Fatigue and hair loss: Although these side effects are common, they are usually temporary and may gradually improve with treatment.

2. Serious side effects that you should be wary of

1. Prolonged QT interval: This is an abnormality on the electrocardiogram that may cause serious heart rhythm problems. Therefore, ECG examination before and after starting treatment is crucial to detect and treat this potential risk in a timely manner.

2.Susceptibility to infection: Due to neutropenia, patients may be more susceptible to infection. Therefore, in addition to regular blood tests, patients should also pay attention to personal hygiene and avoid contact with possible sources of infection.

3.Abnormal liver function: Although uncommon, you still need to be alert to liver function problems that may be caused by Ribociclib. Symptoms such as jaundice and fatigue may be signs of abnormal liver function, and you should seek medical attention immediately if they occur.

Ribociclib (Riboxiclib)as an innovative anti-cancer drug, brings new treatment hope toHR+/HER2- breast cancer patients. However, like all medications, its use comes with certain risks. Through close medical monitoring, reasonable dose adjustment, and patient's own health management, the impact of these side effects can be effectively reduced and the safety and effectiveness of treatment can be ensured. When receiving ribociclib treatment, patients should maintain close communication with their doctors and report any discomfort in a timely manner to ensure the smooth progress of treatment.